✦ LIBER ✦

Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension

✍ Scribed by CS Ceron; MM Castro; E Rizzi; MF Montenegro; V Fontana; MCO Salgado; RF Gerlach; JE Tanus-Santos

Book ID: 111219568
Publisher: Nature Publishing Group
Year: 2010
Tongue: English
Weight: 768 KB
Volume: 160
Category: Article
ISSN: 0007-1188
DOI: 10.1111/j.1476-5381.2010.00678.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lercanidipine reduces matrix metalloprot

Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats

✍ Marcio L.L. Martinez; Michele M. Castro; Elen Rizzi; Karla Fernandes; Caroline D 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 759 KB

Comparative study on antioxidant effects

Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension

✍ Diogo M. O. Marçal; Elen Rizzi; Alisson Martins-Oliveira; Carla S. Ceron; Daniel 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 389 KB

Expression of membrane type 1 matrix met

Expression of membrane type 1 matrix metalloproteinase (MT1-MMP) in A2058 melanoma cells is associated with MMP-2 activation and increased tumor growth and vascularization

✍ Nor Eddine Sounni; Eugenia N. Baramova; Carine Munaut; Erik Maquoi; Francis Fran 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 778 KB

## Abstract Membrane‐type metalloproteinase‐1 (MT1‐MMP) is a transmembrane metalloproteinase overexpressed in tumors, which plays a major role in the first step of pro‐MMP‐2 activation, leading to the generation of an intermediate 62 kDa species. The second step of MMP‐2 activation that yields to t